Frank Cotter, MD
Ophthalmology · Roanoke, VANPI 1932101037
Payments from drug & device makers
Across 582 payments — averaging $1502.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$435K
- AbbVie$419K
- Alcon Research LLC$16K
- Alcon$2K
- NEW World Medical,inc.$518
- Ocular Therapeutix, Inc.$357
- plus $1K from 17 others
What the payments were for
- Speaking & faculty fees$2,67918%
- Travel & lodging$3,29022%
- Food & beverage$9,06860%
- Education$490%
- Gifts$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 206 | $435,118 |
| AbbVie(2 entities) | 255 | $418,948 |
| Alcon Research LLC | 4 | $15,860 |
| Alcon | 54 | $2,069 |
| NEW World Medical,inc. | 4 | $518 |
| Ocular Therapeutix, Inc. | 13 | $357 |
| Bausch & Lomb Americas Inc. | 12 | $313 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $145 |
| Aerie Pharmaceuticals, Inc. | 4 | $128 |
| Genentech, Inc. | 1 | $126 |
| Bausch Health US, LLC | 1 | $102 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $95 |
| Quidel Corporation | 1 | $79 |
| Amgen(2 entities) | 5 | $78 |
| Biotissue Holdings Inc. | 3 | $47 |
| Lensar, Inc. | 1 | $46 |
| Thea Pharma Inc. | 2 | $45 |
| Harrow Eye, LLC | 2 | $34 |
| Seagen Inc. | 1 | $22 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Dompe US, Inc. | 1 | $17 |
| Carl Zeiss Meditec USA, Inc. | 1 | $16 |
| Novartis | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRESERFLO MicroShunt$4,075
- iStent Trabecular Micro-Bypass System Model iS3$2,500
- Kahook Dual Blade$509
- Streamline Surgical System$509
- Ahmed Glaucoma Valve$509
- iDoseTR$415
- XEN GLAUCOMA TREATMENT SYSTEM$357
- LUMIGAN$233
- DURYSTA$220
- KXL System$179
- iStent infinite Trabecular Micro-Bypass System Model iS3$179
- iStent Inject Trabecular Micro-Bypass System$171
- SIMBRINZA$141
- Rocklatan$141
- Rhopressa$141
- AcrySof IQ PanOptix UV IOL$141
- LenSx$132
- NGENUITY$128
- Luxor$128
- VABYSMO$126
How this compares
$874,198 in reported general payments places this provider in the 95th percentile of 509 ophthalmology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 449 | $198,016 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 348 | $97,216 |
| VyzultaLatanoprostene Bunod | 145 | $58,959 |
| RhopressaNetarsudil Mesylate | 50 | $34,660 |
| Dorzolamide Hcl | 1,867 | $29,715 |
| Latanoprost | 4,062 | $28,245 |
| Prednisolone Acetate | 943 | $26,606 |
| Travoprost | 163 | $25,286 |
| CombiganBrimonidine Tartrate/Timolol | 91 | $22,733 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 203 | $21,141 |
| RestasisCyclosporine | 23 | $20,454 |
| Brinzolamide | 84 | $19,302 |
| Alphagan PBrimonidine Tartrate | 30 | $19,147 |
| XiidraLifitegrast | 17 | $16,735 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 923 | $14,594 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Combigan, Restasis, Alphagan P | $418,948 | $260,350593 claims |
| AlconSimbrinza, Azopt | $2,069 | $101,242359 claims |
| Bausch & Lomb Americas Inc.Vyzulta, Xiidra | $313 | $75,694162 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $128 | $47,71988 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate, Prolensa, Lotemax Sm | $145 | $19,30571 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 509 ophthalmology providers in Virginia.
Other ophthalmology in Roanoke
- Karli GriffethRoanoke$64K
- Jerome GoldschmidtRoanoke$41K
- Tad SchoedelRoanoke$17K
- Jonathan TillRoanoke$9K
- James PaauwLynchburg$7M
- Golnaz JaveyLynchburg$6.7M
- Kapil KapoorNorfolk$4.3M
- Ali TabassianRichmond$2.1M
- Elizabeth Yeu-LinNorfolk$2M
- Ethnie JonesRichmond$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.